{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T11:27:22Z","timestamp":1673522842682},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00105-006-1192-x","type":"journal-article","created":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T12:28:50Z","timestamp":1155212930000},"page":"819-830","source":"Crossref","is-referenced-by-count":11,"title":["Raynaud-Ph\u00e4nomen in der Dermatologie"],"prefix":"10.1007","volume":"57","author":[{"given":"C.","family":"Sunderk\u00f6tter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1192_CR1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/01.RES.0000128407.45014.58","volume":"94","author":"Bailey","year":"2004","unstructured":"Bailey SR, Eid AH, Mitra S et al. (2004) Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ Res 94: 1367\u20131374","journal-title":"Circ Res"},{"key":"1192_CR2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(00)05118-7","volume":"357","author":"Block","year":"2001","unstructured":"Block JA, Sequeira W (2001) Raynaud\u2019s phenomenon. Lancet 357: 2042\u20132048","journal-title":"Lancet"},{"key":"1192_CR3","first-page":"752","volume":"17","author":"Boin","year":"2005","unstructured":"Boin F, Wigley FM (2005) Understanding, assessing and treating Raynaud\u2019s phenomenon. Curr Opin Rheumatol 17: 752\u2013760","journal-title":"Curr Opin Rheumatol"},{"key":"1192_CR4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/rheumatology\/35.11.1127","volume":"35","author":"Bukhari","year":"1996","unstructured":"Bukhari M, Herrick AL, Moore T et al. (1996) Increased nailfold capillary dimensions in primary Raynaud\u2019s phenomenon and systemic sclerosis. Br J Rheumatol 35: 1127\u20131131","journal-title":"Br J Rheumatol"},{"key":"1192_CR5","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/0140-6736(90)93307-B","volume":"336","author":"Bunker","year":"1990","unstructured":"Bunker CB, Terenghi G, Springall DR et al. (1990) Deficiency of calcitonin gene-related peptide in Raynaud\u2019s phenomenon. Lancet 336: 1530\u20131533","journal-title":"Lancet"},{"key":"1192_CR6","doi-asserted-by":"crossref","first-page":"H1075","DOI":"10.1152\/ajpheart.2000.278.4.H1075","volume":"278","author":"Chotani","year":"2000","unstructured":"Chotani MA, Flavahan S, Mitra S et al. (2000) Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am J Physiol Heart Circ Physiol 278: H1075\u20131083","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1192_CR7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.CIR.72.3.466","volume":"72","author":"Coffman","year":"1985","unstructured":"Coffman JD, Rasmussen HM (1985) Effects of beta-adrenoreceptor-blocking drugs in patients with Raynaud\u2019s phenomenon. Circulation 72: 466\u2013470","journal-title":"Circulation"},{"key":"1192_CR8","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1529-0131(200008)43:8<1886::AID-ANR27>3.0.CO;2-S","volume":"43","author":"Flavahan","year":"2000","unstructured":"Flavahan NA, Flavahan S, Liu Q et al. (2000) Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma. Arthritis Rheum 43: 1886\u20131890","journal-title":"Arthritis Rheum"},{"key":"1192_CR9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/art.20214","volume":"50","author":"Furspan","year":"2004","unstructured":"Furspan PB, Chatterjee S, Freedman RR (2004) Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud\u2019s disease. Arthritis Rheum 50: 1578\u20131585","journal-title":"Arthritis Rheum"},{"key":"1192_CR10","doi-asserted-by":"crossref","unstructured":"Furspan PB, Chatterjee S, Mayes MD, Freedman RR (2005) Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud\u2019s phenomenon. Rheumatology (Oxford) 44: 488\u2013494","DOI":"10.1093\/rheumatology\/keh517"},{"key":"1192_CR11","doi-asserted-by":"crossref","unstructured":"Herrick AL (2005) Pathogenesis of Raynaud\u2019s phenomenon. Rheumatology (Oxford) 44: 587\u2013596","DOI":"10.1093\/rheumatology\/keh552"},{"key":"1192_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-857X(03)00019-X","volume":"29","author":"Hummers","year":"2003","unstructured":"Hummers LK, Wigley FM (2003) Management of Raynaud\u2019s phenomenon and digital ischemic lesions in scleroderma. Rheum Dis Clin North Am 29: 293\u2013313","journal-title":"Rheum Dis Clin North Am"},{"key":"1192_CR13","first-page":"S19","volume":"22","author":"Kahaleh","year":"2004","unstructured":"Kahaleh MB (2004) Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 22: S19\u201323","journal-title":"Clin Exp Rheumatol"},{"key":"1192_CR14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/art.11364","volume":"50","author":"Kawaguchi","year":"2004","unstructured":"Kawaguchi Y, Takagi K, Hara M et al. (2004) Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum 50: 216\u2013226","journal-title":"Arthritis Rheum"},{"key":"1192_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/1523-1747.ep12360103","volume":"101","author":"Knock","year":"1993","unstructured":"Knock GA, Terenghi G, Bunker CB et al. (1993) Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud\u2019s phenomenon and systemic sclerosis. J Invest Dermatol 101: 73\u201378","journal-title":"J Invest Dermatol"},{"key":"1192_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0741-5214(05)80037-0","volume":"23","author":"Landry","year":"1996","unstructured":"Landry GJ, Edwards JM, McLafferty RB et al. (1996) Long-term outcome of Raynaud\u2019s syndrome in a prospectively analyzed patient cohort. J Vasc Surg 23: 76\u201385; discussion 85\u201376","journal-title":"J Vasc Surg"},{"key":"1192_CR17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0889-857X(05)70295-7","volume":"22","author":"LeRoy","year":"1996","unstructured":"LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22: 675\u2013694","journal-title":"Rheum Dis Clin North Am"},{"key":"1192_CR18","first-page":"70","volume":"20","author":"Maricq","year":"1993","unstructured":"Maricq HR, Carpentier PH, Weinrich MC et al. (1993) Geographic variation in the prevalence of Raynaud\u2019s phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France. J Rheumatol 20: 70\u201376","journal-title":"J Rheumatol"},{"key":"1192_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","volume":"166","author":"Prescott","year":"1992","unstructured":"Prescott RJ, Freemont AJ, Jones CJ et al. (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166: 255\u2013263","journal-title":"J Pathol"},{"key":"1192_CR20","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/art.11060","volume":"48","author":"Rajagopalan","year":"2003","unstructured":"Rajagopalan S, Pfenninger D, Kehrer C et al. (2003) Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud\u2019s phenomenon: implications for vascular dysfunction and progression of disease. Arthritis Rheum 48: 1992\u20132000","journal-title":"Arthritis Rheum"},{"key":"1192_CR21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1","volume":"42","author":"Rajkumar","year":"1999","unstructured":"Rajkumar VS, Sundberg C, Abraham DJ et al. (1999) Activation of microvascular pericytes in autoimmune Raynaud\u2019s phenomenon and systemic sclerosis. Arthritis Rheum 42: 930\u2013941","journal-title":"Arthritis Rheum"},{"key":"1192_CR22","doi-asserted-by":"crossref","unstructured":"Riemekasten G, Sunderk\u00f6tter C (2006) Vasoactive therapies in systemic sclerosis. Rheumatology (Oxford) (in press)","DOI":"10.1093\/rheumatology\/kel283"},{"key":"1192_CR23","doi-asserted-by":"crossref","unstructured":"Rodnan GP, Myerowitz RL, Justh GO (1980) Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) 59: 393\u2013408","DOI":"10.1097\/00005792-198011000-00001"},{"key":"1192_CR24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0002-9343(87)90647-4","volume":"83","author":"Sarkozi","year":"1987","unstructured":"Sarkozi J, Bookman AA, Lee P et al. (1987) Significance of anticentromere antibody in idiopathic Raynaud\u2019s syndrome. Am J Med 83: 893\u2013898","journal-title":"Am J Med"},{"key":"1192_CR25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","volume":"98","author":"Sgonc","year":"1996","unstructured":"Sgonc R, Gruschwitz MS, Dietrich H et al. (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98: 785\u2013792","journal-title":"J Clin Invest"},{"key":"1192_CR26","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.59.11.870","volume":"59","author":"Smyth","year":"2000","unstructured":"Smyth AE, Bell AL, Bruce IN et al. (2000) Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud\u2019s phenomenon. Ann Rheum Dis 59: 870\u2013874","journal-title":"Ann Rheum Dis"},{"key":"1192_CR27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archinte.158.6.595","volume":"158","author":"Spencer-Green","year":"1998","unstructured":"Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158: 595\u2013600","journal-title":"Arch Intern Med"},{"key":"1192_CR28","doi-asserted-by":"crossref","unstructured":"Sunderk\u00f6tter C, Riemekasten G (2006) Pathophysiology and clinical consequences of Raynaud\u2019s phenomenon related to systemic sclerosis. Rheumatology (Oxford) (in press)","DOI":"10.1093\/rheumatology\/kel280"},{"key":"1192_CR29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1600-0625.2001.100602.x","volume":"10","author":"Sunderk\u00f6tter","year":"2001","unstructured":"Sunderk\u00f6tter C, Seeliger S, Schonlau F et al. (2001) Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp Dermatol 10: 391\u2013404","journal-title":"Exp Dermatol"},{"key":"1192_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0049-0172(94)90098-1","volume":"24","author":"ter Borg","year":"1994","unstructured":"ter Borg EJ, Piersma-Wichers G, Smit AJ et al. (1994) Serial nailfold capillary microscopy in primary Raynaud\u2019s phenomenon and scleroderma. Semin Arthritis Rheum 24: 40\u201347","journal-title":"Semin Arthritis Rheum"},{"key":"1192_CR31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ana.20511","volume":"57","author":"Waxman","year":"2005","unstructured":"Waxman SG, Dib-Hajj SD (2005) Erythromelalgia: a hereditary pain syndrome enters the molecular era. Ann Neurol 57: 785\u2013788","journal-title":"Ann Neurol"},{"key":"1192_CR32","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/art.20665","volume":"50","author":"Wise","year":"2004","unstructured":"Wise RA, Wigley FM, White B et al. (2004) Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study. Arthritis Rheum 50: 3994\u20134001","journal-title":"Arthritis Rheum"},{"key":"1192_CR33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0906-6705.2005.00280.x","volume":"14","author":"Yamamoto","year":"2005","unstructured":"Yamamoto T, Nishioka K (2005) Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Exp Dermatol 14: 81\u201395","journal-title":"Exp Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-006-1192-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1192-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:12Z","timestamp":1558568232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-006-1192-x"}},"subtitle":["Teil\u00a01: Pathophysiologie und Diagnostik"],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1007\/s00105-006-1192-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}